MedPath
FDA Approval

Digoxin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Bryant Ranch Prepack
DUNS: 171714327
Effective Date
December 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Digoxin(125 ug in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Bryant Ranch Prepack

171714327

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bryant Ranch Prepack

Bryant Ranch Prepack

Bryant Ranch Prepack

171714327

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Digoxin

Product Details

NDC Product Code
71335-9610
Application Number
ANDA076363
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 3, 2023
DigoxinActive
Code: 73K4184T59Class: ACTIBQuantity: 125 ug in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
HYPROMELLOSE 2208 (15000 MPA.S)Inactive
Code: Z78RG6M2N2Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
© Copyright 2025. All Rights Reserved by MedPath